CTRL and Familial prostate cancer: Although both Ctrl and dCKO mice progressed to prostate cancer at 40 weeks of age (Supplemental Fig. S1g), Kaplan–Meier analysis demonstrated that dCKO mice exhibited shorter overall survival (OS) than the Ctrl group (P = 0.0094, Fig. 1h).